Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Duane Burton

Showing results (71-80 of 102) with videos related to

Pageof 11
Sort By:
Physiological Reports|March 10, 2017
Potential mechanisms of effects of serum-derived bovine immunoglobulin/protein isolate therapy in patients with diarrhea-predominant irritable bowel syndromeNelson Valentin, Michael Camilleri, Paula Carlson, et al.
Diabetes Care|September 11, 2012
Randomized controlled phase Ib study of ghrelin agonist, RM-131, in type 2 diabetic women with delayed gastric emptying: pharmacokinetics and pharmacodynamicsAndrea Shin, Michael Camilleri, Irene Busciglio, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|November 3, 2009
Effects of chenodeoxycholate and a bile acid sequestrant, colesevelam, on intestinal transit and bowel functionSuwebatu T Odunsi-Shiyanbade, Michael Camilleri, Sanna McKinzie, et al.
Obesity (Silver Spring, Md.)|March 24, 2021
Selection of Antiobesity Medications Based on Phenotypes Enhances Weight Loss: A Pragmatic Trial in an Obesity ClinicAndres Acosta, Michael Camilleri, Barham Abu Dayyeh, et al.
The Journal of Clinical Endocrinology and Metabolism|October 26, 2018
GI Dysfunctions in Diabetic Gastroenteropathy, Their Relationships With Symptoms, and Effects of a GLP-1 AntagonistSubhankar Chakraborty, Magnus Halland, Duane Burton, et al.
Digestion|September 21, 2005
Effects of desipramine and escitalopram on postprandial symptoms induced by the nutrient drink test in healthy volunteers: a randomized, double-blind, placebo-controlled studyNicholas J Talley, Michael Camilleri, Denesh K Chitkara, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|May 4, 2013
Bowel functions, fecal unconjugated primary and secondary bile acids, and colonic transit in patients with irritable bowel syndromeAndrea Shin, Michael Camilleri, Priya Vijayvargiya, et al.
American Journal of Physiology. Gastrointestinal and Liver Physiology|July 13, 2004
Effect of oral CCK-1 agonist GI181771X on fasting and postprandial gastric functions in healthy volunteersEmma Janet Castillo, Silvia Delgado-Aros, Michael Camilleri, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|July 23, 2023
A Randomized, Controlled Trial of Efficacy and Safety of Cannabidiol in Idiopathic and Diabetic GastroparesisTing Zheng, Joelle BouSaba, Ann Taylor, et al.
Gastroenterology|March 15, 2011
A Klothoβ variant mediates protein stability and associates with colon transit in irritable bowel syndrome with diarrheaBanny S Wong, Michael Camilleri, Paula J Carlson, et al.
Pageof 11

Showing results (71-80 of 102) with videos related to

Sort By:
Pageof 11
Physiological Reports|March 10, 2017
Potential mechanisms of effects of serum-derived bovine immunoglobulin/protein isolate therapy in patients with diarrhea-predominant irritable bowel syndromeNelson Valentin, Michael Camilleri, Paula Carlson, et al.
Diabetes Care|September 11, 2012
Randomized controlled phase Ib study of ghrelin agonist, RM-131, in type 2 diabetic women with delayed gastric emptying: pharmacokinetics and pharmacodynamicsAndrea Shin, Michael Camilleri, Irene Busciglio, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|November 3, 2009
Effects of chenodeoxycholate and a bile acid sequestrant, colesevelam, on intestinal transit and bowel functionSuwebatu T Odunsi-Shiyanbade, Michael Camilleri, Sanna McKinzie, et al.
Obesity (Silver Spring, Md.)|March 24, 2021
Selection of Antiobesity Medications Based on Phenotypes Enhances Weight Loss: A Pragmatic Trial in an Obesity ClinicAndres Acosta, Michael Camilleri, Barham Abu Dayyeh, et al.
The Journal of Clinical Endocrinology and Metabolism|October 26, 2018
GI Dysfunctions in Diabetic Gastroenteropathy, Their Relationships With Symptoms, and Effects of a GLP-1 AntagonistSubhankar Chakraborty, Magnus Halland, Duane Burton, et al.
Digestion|September 21, 2005
Effects of desipramine and escitalopram on postprandial symptoms induced by the nutrient drink test in healthy volunteers: a randomized, double-blind, placebo-controlled studyNicholas J Talley, Michael Camilleri, Denesh K Chitkara, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|May 4, 2013
Bowel functions, fecal unconjugated primary and secondary bile acids, and colonic transit in patients with irritable bowel syndromeAndrea Shin, Michael Camilleri, Priya Vijayvargiya, et al.
American Journal of Physiology. Gastrointestinal and Liver Physiology|July 13, 2004
Effect of oral CCK-1 agonist GI181771X on fasting and postprandial gastric functions in healthy volunteersEmma Janet Castillo, Silvia Delgado-Aros, Michael Camilleri, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|July 23, 2023
A Randomized, Controlled Trial of Efficacy and Safety of Cannabidiol in Idiopathic and Diabetic GastroparesisTing Zheng, Joelle BouSaba, Ann Taylor, et al.
Gastroenterology|March 15, 2011
A Klothoβ variant mediates protein stability and associates with colon transit in irritable bowel syndrome with diarrheaBanny S Wong, Michael Camilleri, Paula J Carlson, et al.
Pageof 11